D-0789-2026 Class II Ongoing
FDA drug recall D-0789-2026 was initiated by Lupin Pharmaceuticals Inc. on Aug 3, 2026 and is designated Class II. Reason for recall: Failed content uniformity specifications. The recall status is ongoing. Affected quantity: 5082 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 2, 2026
- Initiation Date
- Aug 3, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5082 tubes
Product description
Clobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Pithampur (MP) 454 775, INDIA, NDC 68180-956-04.
Reason for recall
Failed content uniformity specifications.
Distribution pattern
USA Nationwide
Code information
Lot#: KB00427, Exp date 4/30/2028; KA00308, Exp date 10/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0789-2026
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Lupin Pharmaceuticals Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.